Ho-Chun Song1,2, Myung Hwan Na2,3, Jahae Kim1,2, Sang-Geon Cho1,2, Jin Kyung Park2,3, Keon-Wook Kang4. 1. 1Department of Nuclear Medicine, Chonnam National University Hospital, 42 Jebong-ro, Dong-gu, Gwangju, 501-757 South Korea. 2. Medical Radiation Safety Research Center, Gwangju, South Korea. 3. 3Department of Statistics, Chonnam National University, Gwangju, South Korea. 4. 4Department of Nuclear Medicine and Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea.
Abstract
PURPOSE: There is substantial need for optimizing radiation protection in nuclear medicine imaging studies. However, the diagnostic reference levels (DRLs) have not yet been established for nuclear medicine imaging studies in Korea. MATERIALS AND METHODS: The data of administered activity in 32 nuclear medicine imaging studies were collected from the Korean Society of Nuclear Medicine (KSNM) dose survey database from 2013 and 2014. Through the expert discussions and statistical analyses, the 75th quartile value (Q3) was suggested as the preliminary DRL values. Preliminary DRLs were subjected to approval process by the KSNM Board of Directors and KSNM Council, followed by clinical applications and performance rating by domestic institutes. RESULTS: DRLs were determined through 32 nuclear medicine imaging studies. The Q3 value was considered as appropriate selection as it was generally consistent with the most commonly administered activity. In the present study, the final version of initial DRL values for nuclear medicine imaging in Korean adults is described including various protocols of the brain and myocardial perfusion imaging. CONCLUSION: The first DRLs for nuclear medicine imaging in Korean adults were confirmed. The DRLs will enable optimized radiation protection in the field of nuclear medicine imaging in Korea.
PURPOSE: There is substantial need for optimizing radiation protection in nuclear medicine imaging studies. However, the diagnostic reference levels (DRLs) have not yet been established for nuclear medicine imaging studies in Korea. MATERIALS AND METHODS: The data of administered activity in 32 nuclear medicine imaging studies were collected from the Korean Society of Nuclear Medicine (KSNM) dose survey database from 2013 and 2014. Through the expert discussions and statistical analyses, the 75th quartile value (Q3) was suggested as the preliminary DRL values. Preliminary DRLs were subjected to approval process by the KSNM Board of Directors and KSNM Council, followed by clinical applications and performance rating by domestic institutes. RESULTS: DRLs were determined through 32 nuclear medicine imaging studies. The Q3 value was considered as appropriate selection as it was generally consistent with the most commonly administered activity. In the present study, the final version of initial DRL values for nuclear medicine imaging in Korean adults is described including various protocols of the brain and myocardial perfusion imaging. CONCLUSION: The first DRLs for nuclear medicine imaging in Korean adults were confirmed. The DRLs will enable optimized radiation protection in the field of nuclear medicine imaging in Korea.
Entities:
Keywords:
Diagnostic reference level; Dose optimization; Nuclear medicine imaging; Radiopharmaceutical
Authors: Anna Hayton; Anthony Wallace; Paul Marks; Keith Edmonds; David Tingey; Peter Johnston Journal: Australas Phys Eng Sci Med Date: 2013-01-11 Impact factor: 1.430
Authors: José Willegaignon; Luis F E F Braga; Marcelo T Sapienza; George B Coura-Filho; Marissa A R Cardona; Carlos E R Alves; Ricardo F Gutterres; Carlos A Buchpiguel Journal: Nucl Med Commun Date: 2016-05 Impact factor: 1.690